From Saturday, October 28 through Thursday, November 1, members of the University of Notre Dame research community will travel to New Orleans, LA for the annual American Society of Tropical Medicine and Hygiene (ASTMH) meeting. Of the over 40 Notre Dame faculty, researchers, and students in attendance, many will be...

Guido Camargo España, postdoctoral research associate of biological sciences, has received a Postdoctoral Training Award inTranslational Research from the Indiana Clinical and Translational Sciences Institute (CTSI).

What role can Notre Dame play in the revolution building around rare disease research? A collaborative team of stakeholders discussed different options during a working session in October.

Xin Lu, the John M. and Mary Jo Boler Assistant Professor of biology, was awarded a 2018 Susan G. Komen research grant to identify potential new therapies for treating metastatic breast cancer.

Submission Deadline: Dec 10th, 2018 5:00 PM Earliest Start Date. March 1, 2019.   …

Predicting how mutations in proteins alter their ability to function is critical to understanding what drives health and disease in humans. A new study in Structure, Cell Press by scientists at the University of Notre Dame and their colleagues demonstrates how a minor mutation can have far-reaching effects on a...

Perlara, a rare diseases drug discovery company based in the San Francisco Bay area, recently announced a collaboration called PerlQuest with the University of Notre Dame’s Warren Family Research Center for Drug Discovery and Development.

University of Notre Dame doctoral and thesis master’s students can now apply for the Rapid Exposure to Advanced Computational Training (REACT) program.